Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

102.69
+1.631.61%
Post-market: 102.690.00000.00%19:30 EDT
Volume:458.31K
Turnover:46.77M
Market Cap:4.67B
PE:50.09
High:102.89
Open:101.70
Low:100.53
Close:101.06
52wk High:109.57
52wk Low:47.32
Shares:45.45M
Float Shares:44.60M
Volume Ratio:0.81
T/O Rate:1.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.05
EPS(LYR):2.05
ROE:11.20%
ROA:6.60%
PB:5.58
PE(LYR):50.09

Loading ...

BofA Securities Adjusts Price Target on Haemonetics to $100 From $93

MT Newswires Live
·
Aug 13

BofA Securities Adjusts Haemonetics Price Target to $100 From $93

MT Newswires Live
·
Aug 12

Press Release: Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 12

Haemonetics Lifts Outlook on Broad-Based Earnings Strength

TIPRANKS
·
Aug 10

Haemonetics Price Target Raised to $92.00/Share from $79.00 by Citigroup

Dow Jones
·
Aug 08

Barrington Research Adjusts Haemonetics PT to $95 From $89, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

U.S. Research Roundup-Airbnb, Expedia Group, Parker-Hannifin

Reuters
·
Aug 07

Haemonetics Corp : Btig Raises Target Price to $96 from $84

THOMSON REUTERS
·
Aug 07

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA), Haemonetics (HAE) and Nuvation Bio (NUVB)

TIPRANKS
·
Aug 07

Haemonetics Price Target Raised to $96.00/Share from $84.00 by BTIG

Dow Jones
·
Aug 07

Haemonetics Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Haemonetics' Fiscal Q1 Adjusted Earnings, Net Revenue Increase; Fiscal 2027 Outlook Raised

MT Newswires Live
·
Aug 06

Earnings Flash (HAE) Haemonetics Posts Fiscal Q1 Adjusted EPS $1.14, vs. FactSet Est of $0.87

MT Newswires Live
·
Aug 06

Haemonetics Q1 Adj. EPS $1.14 Beats $1.08 Estimate, Sales $339.380M Beat $327.894M Estimate

Benzinga Earnings
·
Aug 06

Haemonetics Outlook FY Organic Growth 4-7%

THOMSON REUTERS
·
Aug 06

Haemonetics Q1 Adjusted EPS USD 1.14 VS. Ibes Estimate USD 1.08

THOMSON REUTERS
·
Aug 06

Haemonetics FY27 Q1 Adjusted EPS Rises 3.6% to $1.14; Revenue Climbs 5.6% to $339.4 Million

Reuters
·
Aug 06

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

THOMSON REUTERS
·
Aug 06

Haemonetics’ Vascade MVP system shows efficacy in electrophysiology study

TIPRANKS
·
Aug 04

Haemonetics Study Shows Vascade MVP XL Posts 1.2% Vascular Complications in 1,623 Large-Bore Electrophysiology Cases

Reuters
·
Aug 04